CANAPAC LDA
CANAPAC LDA is a Portugal-based GMP pharmaceutical contract manufacturer that produces and packages medical cannabis oils and flowers for licensed growers targeting European, Asian, and Middle Eastern regulated markets.
- Company typePrivate
- Founded2021
- HeadquartersCantanhede, Portugal
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CANAPAC LDA does
CANAPAC LDA is a privately held pharmaceutical contract manufacturer and packaging services provider headquartered in Cantanhede, Portugal. Founded in 2021 and operating a GMP-certified facility with ISO8 cleanrooms (per ISO14644-1) in the Cantanhede industrial park, the company is purpose-built to serve licensed medical cannabis growers and producers seeking entry into regulated European, Asian, and Middle Eastern pharmaceutical markets. Its primary offering is contract manufacturing of medical cannabis oils and flowers in multiple dosage forms, covering both THC-rich and non-THC drug products.
The company monetizes through an integrated, one-stop-shop service stack: per-project manufacturing fees (transaction-fee model), in-house chemical and microbiology laboratory testing and stability studies (professional services), regulatory product registration for Portugal and target export markets (professional services), and distribution and storage services via third-party logistics and pharmacy/wholesaler channels (managed services). Supporting capabilities include formulation and product development, and beta-ray radiation sterilization via a third-party partner. The go-to-market is consultative enterprise field sales — prospects are qualified through a 'Reserve your spot on production line' contact form and direct phone outreach — targeting growers who lack in-house GMP infrastructure and need a registered, compliant pathway to launch in regulated markets.
With 23 employees and a 2022 EUR 1.82M Portuguese government grant (Project 179872) funding facility build-out through June 2023, CANAPAC is an early-stage specialty CDMO whose growth is gated by facility qualification, client onboarding, and product registration timelines. The business model is contract-manufacturing centric with vertical (grower/wholesaler) segmentation; no revenue, pricing, or named customer information is publicly disclosed, leaving customer concentration and revenue trajectory as material data gaps for diligence.
CANAPAC LDA firmographics
Firmographics- Name
- CANAPAC LDA
- Legal name
- CANAPAC LDA
- Website
- https://canapac.pt
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CANAPAC LDA is a Portugal-based GMP pharmaceutical contract manufacturer that produces and packages medical cannabis oils and flowers for licensed growers targeting European, Asian, and Middle Eastern regulated markets.
- Ownership category
- akta.pro rank
CANAPAC LDA industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Testing Laboratories (8734)
- akta.pro primary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
- akta.pro secondary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where CANAPAC LDA is headquartered
LocationHeadquarters
- HQ city
- Cantanhede
- HQ country
- Portugal
- HQ region
- Europe
Offices1 record
Markets served
CANAPAC LDA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Pharmaceutical Manufacturing Services: Contract manufacturing of medical cannabis oils and flowers for pharmaceutical products. Services include formulation, processing, and packaging of both THC-rich and non-THC drug products.
- Laboratory and Testing Services: Internal chemical and microbiology lab services providing testing and stability studies for Canapac clients.
- Product Registration Services: Regulatory registration services for Portugal and target export markets in Europe, Asia, and the Middle East.
- Distribution and Storage Services: Warehousing, storage, and distribution services for manufactured products.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CANAPAC LDA product offering
Product offeringCore offering
CANAPAC LDA operates a GMP-certified pharmaceutical contract manufacturing facility in Cantanhede, Portugal, providing manufacturing and packaging of medical cannabis oils and flowers for both THC-rich and non-THC drug products. The company offers integrated services including formulation and product development, in-house chemical and microbiology lab testing, radiation services via third-party, product registration support for Portugal and international markets, and distribution and storage services with access to established pharmaceutical channels across Europe, Asia, and the Middle East.
Product overview
CANAPAC LDA operates as a unified pharmaceutical manufacturing and packaging services platform for the medical cannabis industry, offering an integrated 'one stop shop' solution. The core offerings consist of medical cannabis oils manufacturing and medical cannabis flowers processing under GMP standards. These manufacturing services are supported by add-on modules including formulation development services for custom oils and innovative products, in-house Pharma Lab testing services (chemical and microbiology), radiation service via beta rays through a third party, product registration services for market access in Europe, Asia, and the Middle East, and distribution and storage services with access to sales channels and clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Cannabis Oils Manufacturing
Quantifiable outcome
- Rapid market entry for medical cannabis products in European regulated markets
Companies that use CANAPAC LDA
Customer profileSegments2 records
Ideal customer profiles2 records
CANAPAC LDA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
CANAPAC LDA partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Licensed Growers (Unnamed)coreLong-term collaborations with licensed cannabis growers who supply raw cannabis plant material for processing into pharmaceutical products at CANAPAC's GMP facility.
- Logistics Providers (Unnamed)coreStrategic partnerships with logistics companies enabling storage and distribution services for manufactured medical cannabis products.
- Pharmacies and Wholesalers (Unnamed)coreDistribution partnerships with pharmacies and wholesalers across Europe, Asia, and the Middle East to ensure patient access to high-quality cannabis medicines.
- Clinical Experts and ResearchersminorCollaboration with leading clinical experts and researchers across various therapy areas to develop tailored, effective, and bespoke medical cannabis solutions for clients.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
CANAPAC LDA competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: One of the world's largest pharmaceutical CDMOs with extensive GMP manufacturing and regulatory capabilities. Comparable as a broad pharma CDMO whose entry into cannabis would directly compete with CANAPAC's contract manufacturing proposition.
- Aurora Cannabis: Major Canadian cannabis producer with EU-GMP-certified cultivation and processing for European medical markets. Comparable as a GMP-certified cannabis manufacturer serving international medical channels, albeit with a vertically integrated cultivation model.
- Canopy Growth: Large diversified cannabis company with European medical cannabis operations and GMP manufacturing infrastructure. Comparable in serving international medical cannabis markets with regulated manufacturing capabilities.
- Catalent: Global pharmaceutical CDMO offering softgel, oral dose, and biologics manufacturing. Comparable as a broad pharmaceutical contract manufacturer that could expand into cannabis processing, representing both a potential partner and competitive threat to CANAPAC.
- Tilray Brands: Large global cannabis operator with GMP-certified manufacturing capabilities across multiple geographies. Comparable as an established cannabis manufacturer and exporter to Europe, though at vastly greater scale and broader portfolio than CANAPAC.
Others
- Eurofins Scientific: Global testing laboratory network offering pharmaceutical and cannabis analytical testing services. Comparable to CANAPAC's in-house chemistry/microbiology lab and stability testing capabilities, though Eurofins operates as an outsourced testing partner rather than manufacturer.
Direct peers
- Nextleaf Solutions: Cannabis extraction and processing technology company with focus on producing pharmaceutical-grade cannabis distillate at scale. Comparable to CANAPAC's cannabis processing and oils manufacturing capabilities for medical markets.
- The Valens Company: Canada-based cannabis extraction and product formulation company offering white-label and contract manufacturing services. Comparable to CANAPAC in offering integrated cannabis formulation, manufacturing, and product development for international markets.
- MediPharm Labs: Canadian-headquartered cannabis-focused pharmaceutical contract manufacturer producing GMP-certified cannabis oils and dosage forms for global markets. Most direct peer to CANAPAC given shared focus on GMP cannabis contract manufacturing for international distribution.
Emerging players
- Avicanna: Canadian biopharmaceutical company focused on cannabis-based pharmaceutical product development with research collaborations. Comparable in combining cannabis pharmaceutical R&D with formulation expertise and international regulatory positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CANAPAC LDA social profiles
Digital presenceCANAPAC LDA compliance and trust
Trust signalCompliance1 record
CANAPAC LDA financial estimates
Financial estimateRevenue estimate
Valuation estimate
CANAPAC LDA leadership team
Management profileNumber of profiles
CANAPAC LDA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CANAPAC LDA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CANAPAC LDA
What does CANAPAC LDA do?
CANAPAC LDA operates a GMP-certified pharmaceutical contract manufacturing facility in Cantanhede, Portugal, providing manufacturing and packaging of medical cannabis oils and flowers for both THC-rich and non-THC drug products. The company offers integrated services including formulation and product development, in-house chemical and microbiology lab testing, radiation services via third-party, product registration support for Portugal and international markets, and distribution and storage services with access to established pharmaceutical channels across Europe, Asia, and the Middle East.
Is CANAPAC LDA a public or private company?
CANAPAC LDA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CANAPAC LDA founded?
CANAPAC LDA was founded in 2021. It employs 11 to 50 people.
Where is CANAPAC LDA based?
CANAPAC LDA is headquartered in Cantanhede, Portugal, in the Europe region.
How does CANAPAC LDA make money?
Four revenue lines are on record. Pharmaceutical Manufacturing Services are the primary driver. The others are laboratory and Testing Services, product Registration Services and distribution and Storage Services.
Who are CANAPAC LDA's main competitors?
Broad incumbents on record are Lonza Group, Aurora Cannabis, Canopy Growth, Catalent and Tilray Brands. Eurofins Scientific is listed as an others. Direct peers are Nextleaf Solutions, The Valens Company and MediPharm Labs. Avicanna is listed as an emerging player.
Does CANAPAC LDA have an API?
No public API is recorded for CANAPAC LDA.
What industry is CANAPAC LDA in?
CANAPAC LDA's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325411 and its SIC code is 2834.